Experimental studies and clinical observations with Myelobromol.
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D002241:Carbohydrates / Q000633:toxicity*; D002986:Clinical Trials as Topic; D006801:Humans; D007668:Kidney / Q000473:pathology; D007938:Leukemia / Q000139:chemically induced; D008099:Liver / Q000473:pathology; D055728:Primary Myelofibrosis / Q000139:chemically induced; D011817:Rabbits
D000970:Antineoplastic Agents; D002241:Carbohydrates